Source: Annual Congress 2006 - New findings in the immunology of COPD and interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Miyazaki, M. Kishi, Y. Ohtani, N. Inase, Y. Yoshizawa (Tokyo, Japan). Clinical features of acute exacerbation in chronic birdfancier‘s lung. Eur Respir J 2006; 28: Suppl. 50, 3912

Member's Comments

No comment yet.

Related content which might interest you: Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017 Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002 Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017 Clinical relevance of human bocavirus infection in acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Clinical pathway for acute COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Inpatient acute exacerbations of chronic obstructive pulmonary disease clinical pathway: development and initial experience Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Mechanisms of persistence of Streptococcus pneumoniae following treatment of acute exacerbation of chronic bronchitis Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019